J. J. PLATTNER

917 total citations
25 papers, 722 citations indexed

About

J. J. PLATTNER is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, J. J. PLATTNER has authored 25 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 7 papers in Molecular Biology and 6 papers in Infectious Diseases. Recurrent topics in J. J. PLATTNER's work include HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers) and Click Chemistry and Applications (3 papers). J. J. PLATTNER is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers) and Click Chemistry and Applications (3 papers). J. J. PLATTNER collaborates with scholars based in United States, Russia and Canada. J. J. PLATTNER's co-authors include Daniel W. Norbeck, T. Robins, Dale J. Kempf, Michael Kukulka, Jon F. Denissen, Gondi Kumar, Ann Hsu, Edith McDonald, Kennan C. Marsh and Paolo Baroldi and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Hypertension and Journal of Medicinal Chemistry.

In The Last Decade

J. J. PLATTNER

24 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. J. PLATTNER United States	10	406	293	159	91	89	25	722
Gerry Rhodes United States	11	434 1.1×	273 0.9×	106 0.7×	87 1.0×	80 0.9×	21	709
Jean‐Pierre Sommadossi United States	13	409 1.0×	227 0.8×	119 0.7×	30 0.3×	54 0.6×	18	558
Darren Moss United Kingdom	17	324 0.8×	148 0.5×	234 1.5×	73 0.8×	143 1.6×	30	904
Paul Savina United States	14	525 1.3×	292 1.0×	184 1.2×	19 0.2×	123 1.4×	22	742
Eri Kanaoka Japan	11	182 0.4×	85 0.3×	173 1.1×	91 1.0×	91 1.0×	15	693
Xiao‐Jian Zhou United States	19	475 1.2×	215 0.7×	213 1.3×	141 1.5×	111 1.2×	44	1.0k
Joseph L. Woolley United States	14	233 0.6×	103 0.4×	103 0.6×	31 0.3×	215 2.4×	26	627
Becky Chandler United Kingdom	13	382 0.9×	218 0.7×	89 0.6×	42 0.5×	330 3.7×	16	659
Jennifer E. Vela United States	17	931 2.3×	367 1.3×	317 2.0×	117 1.3×	113 1.3×	19	1.2k
L. Tong United States	8	529 1.3×	261 0.9×	54 0.3×	26 0.3×	117 1.3×	10	648

Countries citing papers authored by J. J. PLATTNER

Since Specialization

Citations

This map shows the geographic impact of J. J. PLATTNER's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. J. PLATTNER with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. J. PLATTNER more than expected).

Fields of papers citing papers by J. J. PLATTNER

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. J. PLATTNER. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. J. PLATTNER. The network helps show where J. J. PLATTNER may publish in the future.

Co-authorship network of co-authors of J. J. PLATTNER

This figure shows the co-authorship network connecting the top 25 collaborators of J. J. PLATTNER. A scholar is included among the top collaborators of J. J. PLATTNER based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. J. PLATTNER. J. J. PLATTNER is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zane, Lee T., et al.. (2015). Tavaborole topical solution, 5% for the treatment of toenailonychomycosis. Drugs of today. 51(10). 599–599. 3 indexed citations

Luan, Qingxian, Tesfahun Desta, Leena Chehab, et al.. (2008). Inhibition of Experimental Periodontitis by a Topical Boron-based Antimicrobial. Journal of Dental Research. 87(2). 148–152. 73 indexed citations

Li, Qun, Thomas J. Sowin, Akiyo Claiborne, et al.. (1999). Practical Synthesis of 2-Pyridone Core: Ethyl 8-Chloro-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizinone-3-carboxylate. Heterocycles. 51(6). 1345–1345. 3 indexed citations

Nellans, H N, et al.. (1998). Motilides and motilactides: Design and development of motilin receptor agonists as a new class of gastrointestinal prokinetic drugs. Drugs of the Future. 23(8). 861–861. 15 indexed citations

Kempf, Dale J., Kennan C. Marsh, Gondi Kumar, et al.. (1997). Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir. Antimicrobial Agents and Chemotherapy. 41(3). 654–660. 310 indexed citations

Sham, Hing L., Chen Zhao, Kennan C. Marsh, et al.. (1995). Potent Inhibitors of the HIV-1 Protease with Good Oral Bioavailabilities. Biochemical and Biophysical Research Communications. 211(1). 159–165. 6 indexed citations

Robins, T. & J. J. PLATTNER. (1993). HIV protease inhibitors: their anti-HIV activity and potential role in treatment.. PubMed. 6(2). 162–70. 59 indexed citations

Chu, Daniel I., et al.. (1993). Convenient access to 2-pyridylindole cytotoxic anticancer agents. Tetrahedron Letters. 34(20). 3259–3262. 1 indexed citations

Kadam, Snehal, et al.. (1992). Reversal of multidrug resistance by two novel indole derivatives.. PubMed. 52(17). 4735–40. 7 indexed citations

10.

CHU, D. T. W., et al.. (1992). Studies directed towards novel penem antibacterials. Tetrahedron Letters. 33(26). 3733–3736. 2 indexed citations

11.

Sham, Hing L., Norman E. Wideburg, Stephen G. Spanton, et al.. (1991). ChemInform Abstract: Synthesis of (2S,5S,4R)‐2,5‐Diamino‐3,3‐difluoro‐1,6‐diphenylhydroxyhexane: The Core Unit of a Potent HIV Proteinase Inhibitor.. ChemInform. 22(22). 1 indexed citations

12.

Stein, Herman H., S.H. Rosenberg, Keith W. Woods, et al.. (1990). Biochemical and pharmacological properties of ABBOTT-65317, a potent renin inhibitor. European Journal of Pharmacology. 183(4). 1306–1307.

13.

Hayashi, Seiji, Daniel W. Norbeck, Robert L. Fine, et al.. (1990). Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro. Antimicrobial Agents and Chemotherapy. 34(2). 287–294. 66 indexed citations

14.

Kleinert, Hollis D., D. Martin, Jay R. Luly, et al.. (1988). Effects of the renin inhibitor A-64662 in monkeys and rats with varying baseline plasma renin activity.. Hypertension. 11(6_pt_2). 613–619. 42 indexed citations

15.

PLATTNER, J. J., et al.. (1983). Preparation of new dihydrofuro[2,3‐f]indole derivatives. Journal of Heterocyclic Chemistry. 20(4). 1059–1062. 5 indexed citations

16.

Harbert, Charles A., J. J. PLATTNER, W. M. WELCH, A. Weissman, & B. Kenneth Koe. (1980). ChemInform Abstract: NEUROLEPTIC ACTIVITY IN 5‐ARYLTETRAHYDRO‐Γ‐CARBOLINES. Chemischer Informationsdienst. 11(42). 1 indexed citations

17.

Herrin, Thomas, et al.. (1980). THIOL ESTERS OF N^α-TOSYL-L-ARGININE. Organic Preparations and Procedures International. 12(3-4). 181–184. 1 indexed citations

18.

Welch, Willard M., et al.. (1978). Analgesic and tranquilizing activity of 5,8-disubstituted 2-aminomethyl-3,4-dihydronaphthalenes. Journal of Medicinal Chemistry. 21(3). 257–263. 1 indexed citations

19.

PLATTNER, J. J., et al.. (1977). Synthesis of optically active 15-thiaprostaglandins. Tetrahedron Letters. 18(19). 1629–1632. 1 indexed citations

20.

PLATTNER, J. J., et al.. (1977). Synthesis of optically active 14-hydroxyprostaglandins. Tetrahedron Letters. 18(29). 2479–2482. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact